Cargando…
Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis
BACKGROUND: Relevant markers of CSCs may serve as prognostic biomarkers of RCC. However, their actual prognostic significance remains inconclusive. Thus, a meta-analysis was performed to reevaluate the association of CSCs-relevant markers (CXCR4, CD133, CD44, CD105) expression with RCC prognosis mor...
Autores principales: | Cheng, Bo, Yang, Guosheng, Jiang, Rui, Cheng, Yong, Yang, Haifan, Pei, Lijun, Qiu, Xiaofu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323198/ https://www.ncbi.nlm.nih.gov/pubmed/27588469 http://dx.doi.org/10.18632/oncotarget.11672 |
Ejemplares similares
-
The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021) -
The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer
por: Cheng, Bo, et al.
Publicado: (2017) -
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018) -
Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma
por: Li, Ge, et al.
Publicado: (2020) -
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
por: Qiu, Xiaofu, et al.
Publicado: (2019)